Skip to search formSkip to main contentSkip to account menu

IPD 1151T

Known as: IPD-1151T 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

suplatast tosilate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Prophylactic Efficacy of IPD【○!R】(Suplatast Tosilate) for Japanese Cedar Pollinosis
Suplatast tosilate is a novel drug which specifically suppresses the production of IgE antibodies. We evaluated the efficacy of… 
1993
1993
[Effects of suplatast tosilate (IPD-1151T) on antibody formations in mice].
We examined the effects of suplatast tosilate (IPD-1151T) on antibody formation in mice, and the following results were obtained… 
1993
1993
306 IPD-1151T の抗原誘発気道反応性亢進抑制作用
1992
1992
Antiallergic agents for atopic dermatitis.Clinical evaluation of IPD-1151T.
アトピー性皮膚炎患者40例に抗アレルギー剤であるIPD-1151 T(トシル酸スプラタスト)を8週間投与し, その臨床効果を検討した。その結果, 皮膚症状は, そう痒, 皮疹とも明らかな改善を示し, 最終全般改善度において中等度改善以上の改善率で79.4… 
1992
1992
Pharmacokinetic Studies of Suplatast tosilate (IPD-1151T) (IV) : Dose dependency and sex difference of Suplatast tosilate (IPD-1151T) in Rats
The dose-dependent pharmacokinetics of suplatast tosilate, (±)-[2-[4-(3-ethoxy-2-hydroxypropoxy) phenylcarbamoyl]ethyl… 
1992
1992
Clinical evaluation of IPD-1151T on allergic rhinitis. Double blind comparative study with Tranilast.
The therapeutic effects of IPD-1151 T, a new anti-allergic agent, were compared with those of Tranilast in 356 patients with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)